Additive interactions of pregabalin with lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model: A type I isobolographic analysis for non-parallel dose-response relationship curves

Epilepsy Research

Volumn 91, Issue 2-3, 2010, Pages 166-175

  Luszczki, Jarogniew J ^a,b   Filip, Damian ^a   Czuczwar, Stanislaw J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Isobolographic analysis; Lamotrigine; Maximal electroshock; Oxcarbazepine; Pregabalin; Topiramate

Indexed keywords

LAMOTRIGINE; OXCARBAZEPINE; PREGABALIN; TOPIRAMATE;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; EVOKED AUDITORY RESPONSE; GRIP STRENGTH; LONG TERM MEMORY; MALE; MOTOR PERFORMANCE; MOUSE; MUSCLE STRENGTH; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SEIZURE; SWISS WEBSTER MOUSE;

ANIMALS; CARBAMAZEPINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ELECTROSHOCK; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; MALE; MICE; PSYCHOMOTOR PERFORMANCE; SEIZURES; TRIAZINES;

EID: 77957018180     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2010.07.009     Document Type: Article

References (29)

1. Bian F., Li Z., Offord J., Davis M.D., McCormick J., Taylor C.P., Walker L.C. Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo autoradiographic study in alpha2-delta type 1 genetically modified mice. Brain Res. 2006, 1075:68-80.
2. Boissier J.R., Tardy J., Diverres J.C. Une nouvelle méthode simple pour explorer l'action tranquilisante: le test de la cheminée. Med. Exp. (Basel) 1960, 3:81-84.
3. Borowicz K.K., Swiader M., Luszczki J., Czuczwar S.J. Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis. Epilepsia 2002, 43:956-963.
4. Brodie M.J. Pregabalin as adjunctive therapy for partial seizures. Epilepsia 2004, 45(Suppl. 6):19-27.
5. Deckers C.L.P., Czuczwar S.J., Hekster Y.A., Keyser A., Kubova H., Meinardi H., Patsalos P.N., Renier W.O., Van Rijn C.M. Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia 2000, 41:1364-1374.
6. Dooley D.J., Donovan C.M., Meder W.P., Whetzel S.Z. Preferential action of gabapentin and pregabalin at P/Q-type voltage-sensitive calcium channels: inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slices. Synapse 2002, 45:171-190.
7. Elger C.E., Brodie M.J., Anhut H., Lee C.M., Barrett J.A. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia 2005, 46:1926-1936.
8. French J.A., Kugler A.R., Robbins J.L., Knapp L.E., Garofalo E.A. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 2003, 60:1631-1637.
9. Leach J.P. Antiepileptic drugs: safety in numbers?. Seizure 2000, 9:170-178.
10. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 1949, 96:99-113.
11. Loewe S. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 1953, 3:285-290.
12. Löscher W., Fassbender C.P., Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res. 1991, 8:79-94.
13. Löscher W., Wauquier A. Use of animal models in developing guiding principles for polypharmacy in epilepsy. Epilepsy Res. 1996, (Suppl. 11):61-65.
14. Luszczki J.J. Isobolographic analysis of interaction between drugs with nonparallel dose-response relationship curves: a practical application. Naunyn Schmiedebergs Arch. Pharmacol. 2007, 375:105-114.
15. Luszczki J.J. Interaction of pregabalin with carbamazepine in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis for non-parallel dose-response relationship curves. Adv. Med. Sci. 2010, 55:1-10.
16. Luszczki J.J., Andres M.M., Czuczwar S.J. Synergistic interaction of gabapentin and oxcarbazepine in the mouse maximal electroshock seizure model-an isobolographic analysis. Eur. J. Pharmacol. 2005, 515:54-61.
17. Luszczki J.J., Antkiewicz-Michaluk L., Czuczwar S.J. Isobolographic analysis of interactions between 1-methyl-1,2,3,4-tetrahydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Eur. J. Pharmacol. 2009, 602:298-305.
18. Luszczki J.J., Antkiewicz-Michaluk L., Raszewski G., Czuczwar S.J. Interactions of 1-methyl-1,2,3,4-tetrahydroisoquinoline with lamotrigine, oxcarbazepine, pregabalin, and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis. Epilepsy Res. 2010, 89:207-219.
19. Luszczki J.J., Czuczwar S.J. Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study. Naunyn Schmiedebergs Arch. Pharmacol. 2004, 369:434-446.
20. Luszczki J.J., Czuczwar S.J. Gabapentin synergistically interacts with topiramate in the mouse maximal electroshock seizure model: an isobolographic analysis. Pharmacol. Rep. 2006, 58:944-954.
21. Luszczki J.J., Wojcik-Cwikla J., Andres M.M., Czuczwar S.J. Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis. Neuropsychopharmacology 2005, 30:958-973.
22. Meyer O.A., Tilson H.A., Byrd W.C., Riley M.T. A method for the routine assessment of fore- and hindlimb grip strength of rats and mice. Neurobehav. Toxicol. 1979, 1:233-236.
23. Micheva K.D., Taylor C.P., Smith S.J. Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons. Mol. Pharmacol. 2006, 70:467-476.
24. Sills G.J. The mechanisms of action of gabapentin and pregabalin. Curr. Opin. Pharmacol. 2006, 6:108-113.
25. Tallarida R.J. Drug Synergism and Dose-Effect Data Analysis 2000, Chapman & Hall/CRC, Boca Raton, USA.
26. Tallarida R.J. An overview of drug combination analysis with isobolograms. J. Pharmacol. Exp. Ther. 2006, 319:1-7.
27. Tallarida R.J. Interactions between drugs and occupied receptors. Pharmacol. Ther. 2007, 113:197-209.
28. Taylor C.P., Angelotti T., Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res. 2007, 73:137-150.
29. Venault P., Chapouthier G., de Carvalho L.P., Simiand J., Morre M., Dodd R.H., Rossier J. Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature 1986, 321:864-866.